1
2
3
Dear Colleagues,
The year 2014 will mark 100 years since the first Head and Neck Cancer Surgery service in the world was established at Memorial Sloan-Kettering Cancer Center in New York City. To celebrate this momentous occasion, The International Federation of Head and Neck Oncologic Societies (IFHNOS) will hold its 5th World Congress in New York from July 26-30, 2014. The American Head and Neck Society (AHNS) will organize and hold its Annual Meeting jointly with this world Congress. This historic conference promises to be the largest and most informative conference in Head and Neck Surgery and Oncology. Experts and leaders from around the globe will present their work and celebrate a Century of Progress in Head and Neck cancer.
We extend an invitation to physicians, surgeons, residents, fellows, research scientists and specialists from all allied fields, as well as speech pathologists, nurses, and all involved and interested in Head and Neck Cancer, to come to New York and participate in this memorable event, which will offer cutting edge knowledge in Head and Neck Oncology. The conference will offer keynote addresses, panels, symposia, debates, video sessions, proffered papers, posters, instruction courses, breakfast sessions and lunch with the professors, giving ample opportunity for individual interaction with world leaders during this four day conference.
An outstanding Social Program is organized for spouses and family. The conference will take place at the Marriott Marquis Hotel in Times Square, in the heart of the Theater District and Broadway in New York City. We look forward to welcoming you to this intellectual and social extravaganza, and the thrill of the big apple, in the summer of 2014…
These are the cities where the wealthy congregate, work, invest, are educated and spend their leisure time. For more interesting infographic : http://www.crowdinvest.com/blog/infographics/
These are the cities where the wealthy congregate, work, invest, are educated and spend their leisure time. For more interesting infographic : http://www.crowdinvest.com/blog/infographics/
ESCRITO ESTA EN ACCIÓN. JOSE, VENDIDO POR SUS HERMANOS..GÉNESIS 37:12-36. (GN...CPV
SE TRATA DE UN TRIPTICO QUE TRATA SOBRE JOSE,Y SUS HERMANOS LO VENDEN A LOS MADIANITAS. SE ENCUENTRA EN GÉNESIS 37:12-36. ADEMAS HAY UN CRUCIGRAMA BÍBLICO SOBRE LA MISMA LECCIÓN, UNA ANÉCDOTA CRISTIANA, ALGUNOS PENSAMIENTOS SABIOS Y UN VERSÍCULO POR MEMORIZAR.
OBRA Y OBREROS EN VENEZUELA. AÑO 2011. BOLETIN No. 48CPV
SE DESCRIBE EL TRABAJO QUE ESTAN REALIZANDO LOS OBREOS A TIEMPO COMPLETO Y OTROS HERMANOS QUE AYUDAN EN LA OBRA DE EVANGELIZACION Y ENSEÑANZA EN VENEZUELA
Displaycia organizes scientific events worldwide on various topics of Medical, Science, Engineering, Technology, Management, and Finance. We strive to produce effective and excellent events that promote global knowledge exchange. By linking academics with business, we promote innovations, research, and strategy. We organize both physical and online events. In order to promote or update research expertise, we kindly invite everyone to participate in Displaycia events. Utilize Displaycia events to strengthen your research or to gain knowledge through promoting, innovating, collaborating, and networking.
The International Association of Oncology is excited to announce “Asia Pacific Cancer Congress” Conference is scheduled on 03rd – 04th December 2021 in Maldives. The Organizing Committee of Oncology genially invites all the specialists, academicians, understudies and business experts in the field of Cancer medicine and Oncology from various parts of the world to take an interest in the upcoming Oncology 2021 gathering.
https://www.asiapacificcancercongress.com
ESCRITO ESTA EN ACCIÓN. JOSE, VENDIDO POR SUS HERMANOS..GÉNESIS 37:12-36. (GN...CPV
SE TRATA DE UN TRIPTICO QUE TRATA SOBRE JOSE,Y SUS HERMANOS LO VENDEN A LOS MADIANITAS. SE ENCUENTRA EN GÉNESIS 37:12-36. ADEMAS HAY UN CRUCIGRAMA BÍBLICO SOBRE LA MISMA LECCIÓN, UNA ANÉCDOTA CRISTIANA, ALGUNOS PENSAMIENTOS SABIOS Y UN VERSÍCULO POR MEMORIZAR.
OBRA Y OBREROS EN VENEZUELA. AÑO 2011. BOLETIN No. 48CPV
SE DESCRIBE EL TRABAJO QUE ESTAN REALIZANDO LOS OBREOS A TIEMPO COMPLETO Y OTROS HERMANOS QUE AYUDAN EN LA OBRA DE EVANGELIZACION Y ENSEÑANZA EN VENEZUELA
Displaycia organizes scientific events worldwide on various topics of Medical, Science, Engineering, Technology, Management, and Finance. We strive to produce effective and excellent events that promote global knowledge exchange. By linking academics with business, we promote innovations, research, and strategy. We organize both physical and online events. In order to promote or update research expertise, we kindly invite everyone to participate in Displaycia events. Utilize Displaycia events to strengthen your research or to gain knowledge through promoting, innovating, collaborating, and networking.
The International Association of Oncology is excited to announce “Asia Pacific Cancer Congress” Conference is scheduled on 03rd – 04th December 2021 in Maldives. The Organizing Committee of Oncology genially invites all the specialists, academicians, understudies and business experts in the field of Cancer medicine and Oncology from various parts of the world to take an interest in the upcoming Oncology 2021 gathering.
https://www.asiapacificcancercongress.com
A Brief History of the Cell Stress Society International.
On its Fifteen Anniversary by Founding President Larry Hightower!
Please view the slide presentation by Larry Hightower which took place at the Montevideo 2014: First Conference of the Latin America Chapter, Cell Stress Society International. Chair: Dr. Maria Bausero.
Cell Stress and Heat Shock Proteins
We invite proposals for paper or poster presentations during a two-day interdisciplinary symposium, hosted by the Brocher Foundation, in Hermance Switzerland.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
5 congress brochure
1. FifthWorld Congress
of International Federation
of Head and Neck
Oncologic Societies (IFHNOS)
Annual Meeting of AHNS
A CENTURY OF PROGRESS
IN HEAD & NECK CANCER
July 26–30, 2014
Marriott Marquis
New York City
WWW.IFHNOS.ORG WWW.AHNS.INFO
Organizer and sponsor Celebrating the 100th Anniversary
of the Head and Neck Program
Hosted by IFHNOS
THE
LARGEST
HEAD & NECK
CANCER
CONGRESS IN
HISTORY
New York
Congress Chairman: Jatin Shah, M.D.
Program Chairman: Bevan Yueh, M.D.
Netherlands
Peru
Norway
Poland
NewZealand
Philippines
Pakistan
Russia
Russia
SouthAfrica
SouthKorea
Thailand
Sweden
UK
Spain
Turkey
Taiwan
USA
Venezuela
Argentina
Canada
Belgium
Denmark
Australia
Chile
Brazil
Egypt
EU
Germany
Greece
Greece
Italy
India
Mexico
HongKong
Japan
Israel
Moldova
Nepal
Croatia
CzechRepublic
Indonesia
IFHNOS Member Nations
Ukraine
Kazakhstan
2. Executive Committee
Jatin Shah
Conference Chair
Bevan Yueh
Program Chair
William Wei
Director, IFHNOS
Terry Day
President, AHNS
Ashok Shaha
Secretary General, IFHNOS
Dennis Kraus
Secretary, AHNS
Alexis Rapidis
Treasurer, IFHNOS
Ehab Hanna
Treasurer, AHNS
Jay Boyle
MSKCC Liasion
Marriott Marquis — Times Square
NYC
July 26 – 30, 2014
Dear Colleagues,
The year 2014, will mark 100 years since the first Head and Neck Cancer Surgery service was established at Memorial Sloan-
Kettering Cancer Center in New York City. To celebrate this momentous occasion, The International Federation of Head and
Neck Oncologic Societies (IFHNOS) will hold its 5th World Congress in New York. The American Head and Neck Society
(AHNS) will hold its Annual Meeting jointly with this world Congress. This historic conference promises to be the largest and
most informative conference in Head and Neck Surgery and Oncology, where experts and leaders from around the globe will
present their work and celebrate a Century of Progress in Head and Neck cancer.
We extend an invitation to physicians, surgeons, residents, fellows, research scientists and specialists from all allied fields, as well
as speech pathologists, nurses, and all involved and interested in Head and neck Cancer, to come to New York and participate in
this memorable event, which will offer cutting edge knowledge in Head and Neck Oncology. The conference will offer keynote
addresses, panels, symposia, debates, video sessions, proffered papers, posters, instruction courses, breakfast sessions and lunch
with the professors, giving ample opportunity for individual interaction with world leaders during this four day conference.
An outstanding Social Program is organized for spouses and family. The conference will take place at the Marriott Marquis Hotel
in Times Square, in the heart of the Theater District and Broadway. We look forward to welcoming you to this intellectual and
social extravaganza, and feel the thrill of the big apple, in the summer of 2014…
Sincerely Yours,
The Executive Committee
3. Breakfast Panels (3) Breakfast Panels (3) Breakfast Panels (3)
Opening Ceremony Debate #1
4 Award Papers +
Argentina Presentation
Debate #3
Hayes Martin Lecture John Conley Lecture Jatin Shah Lecture Milton Dance Lecture
Coffee Coffee Coffee Coffee
Panels(4), Oral Papers (7) President’s Hour Panels(4), Oral Papers (7) Panels(4), Oral Papers (7)
Debate #2
Chris O’Brien Lecture Shah Symposium O’Brien Symposium
AHNS Business Lunch
Lunch w/Prof
Lunch w/Prof
MSKCC Centennial
Program I
Panels(4), Oral Papers (7) Panels(4), Oral Papers (7)
Coffee Coffee
Poster Tour Poster Tour Poster Tour
Welcome Reception Wine and Cheese Reception
/ Past Presidents
MSK Reception Gala Banquet
with Dinner Dance
Panels(4), Oral (7),
Video (2)
Panels(4), Oral (7),
Video (2)
AHNS, IFHNOS Council,
Instuction Courses
7:00 to 8:00
26
Saturday
27
Sunday
28
Monday
29
Tuesday
30
Wednesday
8:00 to 8:45
8:45 to 9:00
9:30 to 10:00
10:00 to 11:00
11:30 to 12:15
11:00 to 11:30
12:15 to 1:15
1:30 to 3:00
3:00 to 3:30
3:30 to 5:00
5:00 to 6:00
7:00 and beyond
Program Grid
6:00 to 7:00
Instuction Courses
Lunch w/Prof
MSKCC Centennial
Program 2
Coffee
Program Committee
Proffered papers
Posters
Panels
Instruction Courses
Lunch with Professors
Breakfast Session
Videos
IFHNOS
Alexis Rapidis
Gopal Iyer
Claudio Cernea
Hisham Mehanna
Jochen Werner
Piero Nicolai
Dan Fliss
AHNS
Doug Girod
Chris Holsinger
Neal Futran
Ellie Maghami
Greg Farwell
Snehal Patel
Eric Moore
Jay O. Boyle
Ian Ganly
Luc G. T. Morris
Snehal G. Patel
Bhuvanesh Singh
Richard J. Wong
MSKCC Centennial Program Committee
Chairman: Bevan Yueh
4. Marcelo Figari (Argentina)
Heinz Stamberger (Austria)
Suren Krishnan (Australia)
Fernando Dias (Brazil)
Patrick Gullane (Canada)
Zhenkun Yu (China)
Miljenko Bura (Croatia)
Hesham Negm (Egypt)
Jean Louis Lefebvre (France)
Jochen Werner (Germany)
Pankaj Chaturvedi (India)
Marlinda Adham (Indonesia)
Piero Nicolai (Italy)
Seiji Kishimoto (Japan)
Rene Leemans (Netherlands)
Randall Morton (New Zealand)
Alfredo Pontejos (Philippines)
Wojciech Golusinski (Poland)
Igor Reshetov (Russia)
Abdul Aziz Bin Ahmed (Saudi Arabia)
Johannes Fagan (South Africa)
Chung Hwan Baek (South Korea)
Manuel Bernal Sprekelson (Spain)
Sheng Po Hao (Taiwan)
Sefik Hosal (Turkey)
Michael Gleeson (UK)
International Advisory Committee
NetherlandsPeru NorwayPoland NewZealandPhilippines PakistanRussia
Russia
SouthAfricaSouthKorea
Thailand
Sweden
UK
Spain
Turkey
Taiwan
USA
Venezuela
Argentina CanadaBelgium DenmarkAustralia ChileBrazil Egypt EU Germany Greece
Greece
Italy
India
Mexico
HongKong
Japan
Israel
MoldovaNepal
Croatia CzechRepublic
Indonesia
Member Nations
Kazakhstan
Ukraine